Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases

Modern Rheumatology

Volumn 10, Issue 1, 2000, Pages 38-44

  Kanazawa, Y ^a   Kaneshiro, Y ^a   Sawa, M ^a   Yasuoka, H ^a   Nojima, T ^a   Ohosone, Y ^a   Mimori, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Autoimmune disease; Calpain; Calpastatin; Rheumatoid arthritis

Indexed keywords

EID: 0346758034     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/s101650070037     Document Type: Article

References (29)

1. Nojima T, Kamata M, Matsunobu T, et al. Detection of autoanti-bodies in sera from patients with rheumatoid arthritis. Jpn J Ftheumatol 1994; 6: 189 – 200.
2. Mimori T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neu-tral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995; 92: 7267 – 71.
3. Despres N, Talbot G, Plouffe B, et al. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibi-tory domains of human calpastatin and its recognition by rheuma-toid arthritis sera. J Clin Invest 1995; 95: 1891 – 6.
4. Asada K, Ishino Y, Shimada M, et al. cDNA cloning of human calpastatin. Sequence homology among human, pig, and rabbit calpastatins. J Enzyme Inhibition 1989; 3: 49 – 56.
5. Emori Y, Kawasaki H, Imajoh H, et al. Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci USA 1987; 84: 3590 – 4.
6. Murachi T. Ca'pain and calpastatin. Trends Biochem Sci 1983; 8: 167 – 9.
7. Inoue M, Kishimoto A, Takai Y, et al. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 1997; 252: 7610 – 6.
8. Kishimoto A, Mikawa K, Hashimoto K, et al. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral pro-tease (calpain). J Biol Chem 1989; 264: 4088 – 92.
9. Pontremoli S, Melloni E, Damiani G, et al. Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutro-phils. J Biol Chem 1988; 263: 1915 – 9.
10. Kobayashi Y, Yamamoto K, Saido T, et al. Identification of calcium-activated neutral protease as a processing enzyme of hu-man interleukin 1 alpha. Proc Natl Acad Sci USA 1990; 87: 5548 – 52.
11. Kunimatsu M, Higashiyama S, Sato K, et al. Calcium dependent cysteine proteinase is a precursor of a chemotactic factor for neutrophils. Biochem Biophys Res Commum 1989; 164: 875 – 82.
12. Fukui I, Tanaka K, Murachi K. Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem Biophys Res Commun 1989; 162: 559 – 66.
13. Suzuki K, Shimizu K, Hamamoto T, et al. Biochemical demonstra-tion of calpains and calpastatin in osteoarthritic synovial fluid. Arthritis Rheum 1990; 33: 728 – 32.
14. Yamamoto S, Shimizu K, Shimizu K, et al. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 1992; 35: 1309 – 17.
15. Suzuki K, Shimizu K, Hatamoto T, et al. Characterization of proteoglycan degradation by calpain. Biochem J 1992; 285: 857 – 62.
16. Menard HA, El-Amine M. The calpain-calpastatin system in rheu-matoid arthritis. Immunol Today 1996; 17: 545 – 7.
17. Mimori T, Suganuma K, Tanami Y, et al. A pathogenic role of autoantibodies to calpastatin in patients with rheumatoid arthritis (abstract). Arthritis Rheum 1995; 38: 5165.
18. Arnett FC, Edworthy S, Block DA, et al. The 1987 revised AFtA criteria for rheumatoid arthritis. Arthritis Rheum 1988; 31: 315 – 24.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271 – 7.
20. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1981; 23: 581 – 90.
21. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344 – 7.
22. Mimori T, Ohosone Y, Hama N, et al. Isolation and characteriza-tion of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from pa-tients with sderoderma-polymyositis overlap syndrome. Proc Natl Acad Sci USA 1990; 87: 1777 – 81.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of pro-teins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350 – 4.
24. Lee JL, Ma H, Takano E, et al. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J Biol Chem 1992; 267: 8437 – 42.
25. Harbets WJ, Winand WJ, Sillekens PTG, et al. Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B cell epitopes. Proc Natl Acad Sci USA 1989; 86: 4674 – 8.
26. Kohsaka H, Yamamoto K, Fujii H, et al. Fine epitope mapping of the human SS-B/La protein: identification of a distinct autoepitope homologous to a viral gag polyprotein. J Chin Invest 1990; 85: 1566 – 74.
27. Ohosone Y, Mimori T, Fujii T, et al. Autoantigenic epitopes of the B polypeptide of Sm small nuclear FtNP particles. Identification of regions accessible only within the Ul small nuclear FtNP. Arthritis Rheum 1992; 35: 960 – 6.
28. Reeves WH, Pierani A, Chou CH, et al. Epitopes of the p70 and p80 (Ku) lupus autoantigens. J Immunol 1991; 146: 2678 – 86.
29. Kuwana M, Kaburaki J, Mimori T, et al. Autoantigenic epitopes on DNA topoisomerase. I: Clinical and immunogenetic associations in systemic sclerosis. Arthritis Rheum 1993; 36: 1406 – 13.